| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.20B | +20.0% |
| Cost of Revenue | $422.5M | +12.1% |
| Gross Profit | $777.3M | +24.8% |
| R&D Expense | $239.5M | +9.5% |
| SG&A Expense | $132.3M | +27.6% |
| Operating Income | $162.3M | +37.9% |
| Pre-tax Income | $116.0M | +54.6% |
| Income Tax | $19.3M | +0.0% |
| Net Income | $96.7M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $295.9M | -26.7% |
| Accounts Receivable | $118.0M | +12.5% |
| Current Assets | $477.7M | -14.3% |
| Total Assets | $3.45B | +9.0% |
| Current Liabilities | $156.3M | +33.5% |
| Long-term Debt | $1.06B | +20.7% |
| Total Liabilities | $1.33B | +18.1% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $339.9M | +40.0% |
| Capital Expenditures | $2.1M | +23.0% |
| Investing Cash Flow | -$505.5M | -997.0% |
| Financing Cash Flow | $57.6M | +222.4% |
| Free Cash Flow | $337.8M | +40.1% |
| +73.6% |
| EPS (Basic) | $1.11 | +70.8% |
| EPS (Diluted) | $1.09 | +70.3% |
| Stockholders' Equity |
| $2.11B |
| +3.9% |